We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Targets Alternative, Unapproved Diabetes Drugs
FDA Targets Alternative, Unapproved Diabetes Drugs
July 26, 2013
Fifteen makers of unapproved diabetes drugs received warning letters from the FDA last week in a crackdown on products backed by questionable marketing claims and uncertain manufacturing practices.